How many drugs treat Binge Eating Disorder?

Drug Landscape tracks 2 marketed treatments for Binge Eating Disorder (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/binge-eating-disorder.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Binge Eating Disorder — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Binge Eating Disorder (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Binge Eating Disorder, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Vyvanse	LISDEXAMFETAMINE	Takeda	Central Nervous System Stimulant	Sodium-dependent dopamine transporter		2007-01-01
Vyvanse	Vyvanse	Vanderbilt University		Sodium-dependent dopamine transporter, Sodium-dependent noradrenaline transporter, Synaptic vesicular amine transporter

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Binge Eating Disorder
Takeda · 1 drug in Binge Eating Disorder
Vanderbilt University · 1 drug in Binge Eating Disorder

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Binge Eating Disorder:

Cite this brief

Drug Landscape (2026). Binge Eating Disorder — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/binge-eating-disorder. Accessed 2026-06-10.

Binge Eating Disorder full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing